Page last updated: 2024-10-29

iomeprol and Carcinoma, Pancreatic Ductal

iomeprol has been researched along with Carcinoma, Pancreatic Ductal in 3 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muenzfeld, H1
Mahjoub, S1
Roehle, R1
Pelzer, U1
Bahra, M1
Boening, G1
Hamm, B1
Geisel, D1
Auer, TA1
Noda, Y1
Goshima, S1
Kawada, H1
Kawai, N1
Miyoshi, T1
Matsuo, M1
Bae, KT1
Loizou, L1
Albiin, N1
Leidner, B1
Axelsson, E1
Fischer, MA1
Grigoriadis, A1
Del Chiaro, M1
Segersvärd, R1
Verbeke, C1
Sundin, A1
Kartalis, N1

Trials

1 trial available for iomeprol and Carcinoma, Pancreatic Ductal

ArticleYear
Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality.
    European radiology, 2016, Volume: 26, Issue:11

    Topics: Aged; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Humans; Iopamidol; Male; Multidetector C

2016

Other Studies

2 other studies available for iomeprol and Carcinoma, Pancreatic Ductal

ArticleYear
Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.
    European journal of radiology, 2019, Volume: 119

    Topics: Aged; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Clinical Pr

2019
Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma.
    AJR. American journal of roentgenology, 2018, Volume: 210, Issue:6

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Contrast M

2018